Last reviewed · How we verify

Cefadroxil tablets manufactured by GSK — Competitive Intelligence Brief

Cefadroxil tablets manufactured by GSK (Cefadroxil tablets manufactured by GSK) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: First-generation cephalosporin. Area: Infectious Disease.

marketed First-generation cephalosporin Penicillin-binding proteins (PBPs) Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Cefadroxil tablets manufactured by GSK (Cefadroxil tablets manufactured by GSK) — GlaxoSmithKline. Cefadroxil inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins and cross-linking peptidoglycan strands.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Cefadroxil tablets manufactured by GSK TARGET Cefadroxil tablets manufactured by GSK GlaxoSmithKline marketed First-generation cephalosporin Penicillin-binding proteins (PBPs)
CEPHALEXIN CEPHALEXIN marketed First-generation cephalosporin Penicillin-binding proteins (PBPs) 1971-01-01
Cefadroxil until drain removal Cefadroxil until drain removal Stony Brook University marketed First-generation cephalosporin Penicillin-binding proteins (PBPs)
Cefazolin PostOperatively Cefazolin PostOperatively Aultman Health Foundation marketed First-generation cephalosporin Penicillin-binding proteins (PBPs)
Cefazolin 2 GM Injection Cefazolin 2 GM Injection Abdul El-Rabbany marketed First-generation cephalosporin Penicillin-binding proteins (PBPs)
Bolus dose of Cefazolin Bolus dose of Cefazolin University of Florida marketed First-generation cephalosporin Penicillin-binding proteins (PBPs)
Cefadroxil tablets manufactured by NP Cefadroxil tablets manufactured by NP GlaxoSmithKline marketed First-generation cephalosporin Penicillin-binding proteins (PBPs)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (First-generation cephalosporin class)

  1. Aultman Health Foundation · 2 drugs in this class
  2. GlaxoSmithKline · 2 drugs in this class
  3. Stony Brook University · 2 drugs in this class
  4. · 1 drug in this class
  5. Abdul El-Rabbany · 1 drug in this class
  6. University of Florida · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Cefadroxil tablets manufactured by GSK — Competitive Intelligence Brief. https://druglandscape.com/ci/cefadroxil-tablets-manufactured-by-gsk. Accessed 2026-05-17.

Build your own brief

Pick any drug + add comparators: